Jinwan Wang
Impact in
- Oncology top 2%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Gastroenterology top 2%
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- Gastric Cancer Management and Outcomes 15
- Renal cell carcinoma treatment 13
- Oncology 28
- Colorectal Cancer Treatments and Studies 12
- Lung Cancer Research Studies 9
- HER2/EGFR in Cancer Research 4
- Co-authors
- Wentao Mao (7 shared papers)Yihebali Chi (17 shared papers)Yongkun Sun (17 shared papers)Ling He (3 shared papers)Feng Du (6 shared papers)Hao Yu (4 shared papers)Rui‐Hua Xu (9 shared papers)Jianming Xu (7 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)The Oncologist (2 papers)Journal of Surgical Oncology (2 papers)BMC Cancer (2 papers)Gastric Cancer (2 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Jinwan Wang
91 papers receiving 2.8k citations
Jinwan Wang's Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 1.1k
- Gastroenterology 209
- Pulmonary and Respiratory Medicine 1.1k
- Pathology and Forensic Medicine 166
- Cancer Research 134
Countries citing papers authored by Jinwan Wang
This map shows the geographic impact of Jinwan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinwan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinwan Wang more than expected).
Fields of papers citing papers by Jinwan Wang
This network shows the impact of papers produced by Jinwan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinwan Wang. The network helps show where Jinwan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinwan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study Hit paper breakdown → | 2014 | 492 |
| 2 | Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors Hit paper breakdown → | 2016 | 338 |
| 3 | 2018 | 256 | |
| 4 | 2016 | 198 | |
| 5 | 2014 | 191 | |
| 6 | 2018 | 94 | |
| 7 | 2013 | 91 | |
| 8 | 2019 | 81 | |
| 9 | 2015 | 79 | |
| 10 | 2016 | 75 | |
| 11 | 2008 | 71 | |
| 12 | 2012 | 51 | |
| 13 | 2016 | 48 | |
| 14 | 2017 | 44 | |
| 15 | 2014 | 44 | |
| 16 | 2015 | 38 | |
| 17 | 2013 | 37 | |
| 18 | [Randomized phase II trial on escalated doses of Rh-endostatin (YH-16) for advanced non-small cell lung cancer]. | 2006 | 35 |
| 19 | 2017 | 30 | |
| 20 | 2022 | 25 |
About Jinwan Wang
Jinwan Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Epidemiology and Artificial Intelligence, having authored 95 papers that have together received 2.8k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (15 papers), Renal cell carcinoma treatment (13 papers), Colorectal Cancer Treatments and Studies (12 papers), Lung Cancer Research Studies (9 papers), Machine Learning and ELM (7 papers), Neuroendocrine Tumor Research Advances (7 papers), Face and Expression Recognition (5 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Oncology (1.1k citations), Gastroenterology (209 citations), Pulmonary and Respiratory Medicine (1.1k citations), Pathology and Forensic Medicine (166 citations) and Cancer Research (134 citations). Jinwan Wang has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Wentao Mao, Yihebali Chi, Yongkun Sun, Ling He, Feng Du, Hao Yu, Rui‐Hua Xu, Jianming Xu, Chunxia Du and Shuting Li. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, Journal of Surgical Oncology, BMC Cancer and Gastric Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.